1. Hunter DG, Foster CS. Albert DM, Jakobiec FA, editors. Ocular manifestations of sarcoidosis. Principles and Practice of Opthalmology. 1994. Philadelphia: WB Saunders;1217–1224.
2. Obenauf CD, Shaw HE, Sydnor CF, Klintworth GK. Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol. 1978. 86:648–655.
Article
3. James DG, Anderson R, Langley D, Ainslie D. Ocular sarcoidosis. Br J Ophthalmol. 1964. 48:461–470.
Article
4. Karma A. Ophthalmic changes in sarcoidosis. Acta Ophthalmol Suppl. 1979. 141:1–94.
5. Jabs DA, Johns CJ. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol. 1986. 102:297–301.
Article
6. Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997. 145:234–241.
Article
7. Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, Eklund A, Kitaichi M, Lynch J, Rizzato G, Rose C, Selroos O, Semenzato G, Sharma OP. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/ World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999. 16:149–173.
8. Kim DS. Sarcoidosis in Korea: report of the second nationwide survey. Sarcoidosis Vasc Diffuse Lung Dis. 2001. 18:176–180.
9. Hosoda Y, Yamaguchi M, Hiraga Y. Global epidemiology of sarcoidosis. What story do prevalence and incidence tell us? Clin Chest Med. 1997. 18:681–694.
10. BenEzra D, Rorrester JV, Nussenblat RB. Uveitis Scoring System. Berlin: Springer-Verlag;1–13.
11. James DG, Neville E, Langley DA. Ocular sarcoidosis. Trans Ophthalmol Soc U K. 1976. 96:133–139.
Article
12. Rothova A, Alberts C, Glasius E, Kijlstra A, Buitenhuis HJ, Breebaart AC. Risk factors for ocular sarcoidosis. Doc Ophthalmol. 1989. 72:287–296.
Article
13. Iwata K, Nanba K, Sobue K, Abe H. Ocular sarcoidosis: evaluation of intraocular findings. Ann N Y Acad Sci. 1976. 278:445–454.
Article
14. Yamaguchi M, Hosoda Y, Sasaki R, Aoki K. Epidemiological study on sarcoidosis in Japan. Recent trends in incidence and prevalence rates and changes in epidemiological features. Sarcoidosis. 1989. 6:138–146.
15. Ohara K, Okubo A, Sasaki H, Kamata K. Intraocular manifestations of systemic sarcoidosis. Jpn J Ophthalmol. 1992. 36:452–457.
16. Lobo A, Barton K, Minassian D, du Bois RM, Lightman S. Visual loss in sarcoid-related uveitis. Clin Experiment Ophthalmol. 2003. 31:310–316.
Article
17. Khalatbari D, Stinnett S, McCallum RM, Jaffe GJ. Demographic-related variations in posterior segment ocular sarcoidosis. Ophthalmology. 2004. 111:357–362.
Article
18. Thorne JE, Brucker AJ. Choroidal white lesions as an early manifestation of sarcoidosis. Retina. 2000. 20:8–15.
Article
19. Lardenoye CW, Van der Lelij A, de Loos WS, Treffers WF, Rothova A. Peripheral multifocal chorioretinitis: a distinct clinical entity? Ophthalmology. 1997. 104:1820–1826.
20. Hershey JM, Pulido JS, Folberg R, Folk JC, Massicotte SJ. Non-caseating conjunctival granulomas in patients with multifocal choroiditis and panuveitis. Ophthalmology. 1994. 101:596–601.
Article
21. Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS. Prognosticators for visual outcome in sarcoid uveitis. Ophthalmology. 1996. 103:1846–1853.
Article
22. Bardelli AM, Barberi L, Vanni M, Mazzera L, Traversi C. Eye involvement in sarcoidosis: survey of 197 patients. Sarcoidosis. 1993. 10:158–159.
23. Sugisaki K, Yamaguchi T, Nagai S, Ohmiti M, Takenaka S, Morimoto S, Ishihara M, Tachibana T, Tsuda T. Clinical characteristics of 195 Japanese sarcoidosis patients treated with oral corticosteroids. Sarcoidosis Vasc Diffuse Lung Dis. 2003. 20:222–226.